The DOI matches its Crossref record; the references it cites are not checked yet.
Antitumoral Efficacy of AuNRs‐Laden ECFCs In Vitro and In Vivo: Decoding the Heat and Rays Combo Treatment in Breast Cancer and Melanoma Cells
Open accessAbstract
Radiotherapy remains a cornerstone in metastatic cancer treatment but is often hindered by tumor hypoxia and radioresistance. Gold nanorods (AuNRs) offer promise in enhancing radiotherapy through hyperthermia, yet their clinical impact is limited by poor tumor targeting. Building on the previous findings demonstrating the tumor‐homing ability of Endothelial Colony Forming Cells (ECFCs) loaded with AuNRs, this study advances their use as a biologically targeted delivery system for precise radiotherapy enhancement. Using 3D in vitro tumor models and in vivo studies with nude rats, it is demonstrated that ECFCs actively home to hypoxic tumor regions, overcoming traditional nanoparticle delivery limitations. This targeted approach ensures efficient AuNR accumulation, enhancing photothermal activation and maximizing radiosensitization. In vitro, ECFC‐loaded AuNRs significantly amplify radiotherapy effects, inducing ferroptosis in melanoma and inhibiting autophagy in breast cancer cells—revealing distinct tumor‐specific mechanisms. Moreover, ECFC‐AuNRs suppress tumor proliferation and angiogenesis, blocking vessel‐like structure formation in vitro and in vivo. By integrating cellular therapy with nanotechnology, this study presents a novel strategy to counter radioresistance and improve therapeutic precision. These findings lay the foundation for a clinically viable, patient‐specific approach, unlocking new possibilities in advanced cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The route of administration also remains a practical limitation, as intratumoral delivery may not be feasible for all anatomical sites, whereas systemic administration raises concerns regarding off-target accumulation and toxicity [25,97].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These systems established the proof-of-concept that nanomaterials could enhance radiation-induced damage, but they also highlighted important limitations related to tumor hypoxia, antioxidant defenses, heterogeneous intratumoral distribution, and variable nanoparticle accumulation [11,12,25,95,97].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [25]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Although these combinatorial systems often demonstrate enhanced efficacy experimentally, their clinical development is challenged by issues related to reproducibility, manufacturing consistency, regulatory approval, scalability, and long-term safety [25,96,97].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [25]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 93 · Cited by 7
Research works printed but not linked: 3
- Breur K., 1973, Arch Chir Neerl, 25, 341
- Sacks D., 2018, Int. J. Stroke, 13, 612
- Balakrishnan P. B., 2021, Front. Immunol., 12
Metadata
- Authors
- Anceschi, C., Scavone, F., Armanetti, P., Menichetti, L., Catarinicchia, C., Borri, C., Ratto, F., Micheletti, F., Formica, N., Ruzzolini, J., Frediani, E., Chillà, A., Margheri, F., Severi, M., Traversi, R., Nardini, P., Guasti, D., Del Rosso, M., Del Rosso, T., Giovanelli, L., Talamonti, C., Mangoni, M., Desideri, I., Burchielli, S., Pajar, F., Fibbi, G., & Laurenzana, A.
- Affiliations
- University of Florence (IT)
- Istituto di Fisiologia Clinica (IT)
- Nello Carrara Institute of Applied Physics (IT)
- Department of Experimental and Clinical Biomedical Sciences University of Florence Viale Morgagni 50 Florence 50134 Italy
- Department of Physics Pontifical Catholic University of Rio de Janeiro Rua Marquês de São Vicente 225, Gávea Rio de Janeiro 22451–900 Brazil
- National Research Council (IT)
- Department of Translational Research and New Technologies, St. Chiara Hospital University of Pisa Via Savi, 10 Pisa 56100 Italy
- Corresponding author
- Fibbi, Gabriella
- Laurenzana, Anna
- ORCID
- Anceschi, Cecilia
- Armanetti, Paolo
- Menichetti, Luca
- Borri, Claudia
- Ratto, Fulvio
- Micheletti, Filippo
- Ruzzolini, Jessica
- Chillà, Anastasia
- Margheri, Francesca
- Severi, Mirko
- Traversi, Rita
- Nardini, Patrizia
- Guasti, Daniele
- Talamonti, Cinzia
- Mangoni, Monica
- Desideri, Isacco
- Burchielli, Silvia
- Fibbi, Gabriella
- Laurenzana, Anna
- Venue
- Advanced Healthcare Materials
- Publisher
- Wiley
- Published
- 2025-06-23
- Volume
- 14
- Issue
- 22
- Pages
- e2502416-e2502416
- ISSN
- 2192-2640 (ISSN-L)
- 2192-2659
- PMC
- PMC12391628
- OpenAlex
- W4411570731
- Cited by
- 7
- References
- 93
- Citations by year
- 2026: 4 · 2025: 3
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Advanced Healthcare Materials (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Florence Research (University of Florence) (submittedVersion, cc-by)
- Funders
- Associazione Italiana per la Ricerca sul Cancro (IG 2020 N. 24381)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- gold nanorods, endothelial colony-forming cells, radiosensitization, radiotherapy, photothermal therapy, tumor hypoxia, tumor targeting, ferroptosis, autophagy inhibition, breast cancer, melanoma, angiogenesis inhibition, cell therapy, radioresistance (biology)
- MeSH terms
- Animals, Autophagy, Breast Neoplasms, Female, Gold, Humans, Melanoma, Rats, Nude, Endothelial Cells, Nanotubes, Cell Line, Tumor, Cell Proliferation, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antitumoral Efficacy of AuNRs‐Laden ECFCs In Vitro and In Vivo: Decoding the Heat and Rays Combo Treatment in Breast Cancer and Melanoma Cells. https://app.cochat.ai/papers/10.1002/adhm.202502416
- The paper
- Anceschi, C., Scavone, F., Armanetti, P., Menichetti, L., Catarinicchia, C., Borri, C., Ratto, F., Micheletti, F., Formica, N., Ruzzolini, J., Frediani, E., Chillà, A., Margheri, F., Severi, M., Traversi, R., Nardini, P., Guasti, D., Del Rosso, M., Del Rosso, T., . . . Laurenzana, A. (2025). Antitumoral Efficacy of AuNRs‐Laden ECFCs In Vitro and In Vivo: Decoding the Heat and Rays Combo Treatment in Breast Cancer and Melanoma Cells. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202502416
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.